Introduction

Dechra

Company name: Dechra Veterinary Products

Address: (A business unit of Dechra Pharmaceuticals PLC)

Cartmel Drive

Harlescott

Shrewsbury SY1 3TB

Telephone: 01743 441632

Fax: 01743 462111

Email: info@dechra-uk.com

Website: www.dechra-uk.com

Presentation

White, flat tablets with a bevelled edge and a break-line.

Each tablet contains:

Paracetamol	400 mg
Codeine Phosphate	9 mg

Uses

For analgesic therapy in the dog only. The product is indicated for acute pain of traumatic origin, as a complementary treatment in pain associated with other conditions, and post operative analgesia.

Dosage and administration

For oral administration.

1 tablet per 12 kg bodyweight every 8 hours.

Small dogs (up to 6 kg bodyweight): ½ tablet every 8 hours.

Medium dogs (6–18 kg bodyweight): ½–1½ tablets every 8 hours.

Large dogs (18–42 kg bodyweight): 1½–3½ tablets every 8 hours.

Treat for a maximum of 5 days.

Contra-indications, warnings, etc

Do not exceed the stated dose or the duration of treatment.

Do not administer other NSAIDs concurrently or within 24 hours of each other.

Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastrointestinal ulceration or bleeding, or where there is evidence of blood dyscrasia or hypersensitivity to the product.

Do not use this preparation for cats.

Use in animals less than 6 weeks of age, or in aged animals, may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management.

Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.

Some NSAIDS may be highly bound to plasma proteins and compete with other highly bound drugs to produce an increase in non-bound pharmacologically active concentrations, which can lead to toxic effects.

Concurrent administration of potentially nephrotoxic drugs should be avoided.

If you notice any serious effects or other effects not mentioned in the leaflet, please inform your veterinary surgeon.

Overdosage: Immediately seek the advice of a veterinary surgeon showing them the product literature.

Carry out lavage and treat with an intravenous injection of Acetylcysteine (200 mg/ml) at a rate of 140 mg/kg every 6 hours for 7 treatments. Ascorbic Acid (30 mg/kg) should also be given orally with each dose of Acetylcysteine. If necessary, instigate fluid therapy using Ringers or Bicarbonate Solution. Treat for Codeine overdosing with intravenous injections of Naloxone (1.0 mg/kg) repeated as necessary. Provide Oxygen support.

Side effects: Occasional constipation due to Codeine content.

Operator warnings: Wash hands after use.

General precautions: For animal treatment only.

Pharmaceutical precautions

Do not store above 25°C. Keep out of the reach and sight of children.

Do not use after the expiry date stated on the blister.

Disposal: Dispose of empty packaging and any remaining product in the household refuse.

Legal category

NFA-VPS

Packaging Quantities

Containers of 100 and 500 tablets.

Further information

NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections, appropriate concurrent antimicrobial therapy should be instigated.

Seek veterinary advice if the treated condition does not improve or worsens during treatment.

UK authorised veterinary medicinal product.